Services
- Preclinical
- Early Phase
Who We Serve
START Locations
About
- Company
- Leadership
- Principal Investigators
- Careers
- Resources
  - Blog
  - Events
  - Newsroom
  - Patient Stories
  - Press
  - Publications
  - Webinars
- Contact
Patients & Family
Referring Physicians
Find a Trial

Services
- Preclinical
- Early Phase
Who We Serve
START Locations
About
- Company
- Leadership
- Principal Investigators
- Careers
- Resources
  - Blog
  - Events
  - Newsroom
  - Patient Stories
  - Press
  - Publications
  - Webinars
- Contact
Patients & Family
Referring Physicians
Find a Trial

Press

New Clinical Trial Unit Opens for Irish Cancer Patients

New Clinical Trial Unit Opens for Irish Cancer Patients Read More »

‘I Had No Lesions On My Skin. It Happens in 5pc of Cases’ – Dublin Woman Reached Stage Four Cancer Before Getting Access to Therapy

‘I Had No Lesions On My Skin. It Happens in 5pc of Cases’ – Dublin Woman Reached Stage Four Cancer Before Getting Access to Therapy Read More »

‘A Day of Hope’: Irish Hospital Patients Get Access to ‘Early Phase’ Cancer Drugs

Leave a Comment / Press / Joel E

‘A Day of Hope’: Irish Hospital Patients Get Access to ‘Early Phase’ Cancer Drugs Read More »

First Patient Dosed with NILK-2401 in Phase I Clinical Trial

Leave a Comment / Press / Joel E

First Patient Dosed with NILK-2401 in Phase I Clinical Trial Read More »

DPharm 2024: Problem Solving in the Clinical Trial Realm

Leave a Comment / Press / Joel E

DPharm 2024: Problem Solving in the Clinical Trial Realm Read More »

Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor

Leave a Comment / Press / Joel E

Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor Read More »

MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor

Leave a Comment / Press / Joel E

MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor Read More »

Why Moving More Cancer Trials Into the Community Benefits Patients and Sponsors

Leave a Comment / Press / Joel E

Why Moving More Cancer Trials Into the Community Benefits Patients and Sponsors Read More »

Biotheryx Announces First Patient Dosed in Phase 1 Clinical Trial of BTX-9341, a First-in-Class, Dual Bifunctional Degrader of CDK4/6, as a Monotherapy and in Combination with Fulvestrant for HR+/HER2- Breast Cancer

Leave a Comment / Press / Joel E

Biotheryx Announces First Patient Dosed in Phase 1 Clinical Trial of BTX-9341, a First-in-Class, Dual Bifunctional Degrader of CDK4/6, as a Monotherapy and in Combination with Fulvestrant for HR+/HER2- Breast Cancer Read More »

Enabling Successful Sites Ep. 3: Taking the Complexity Out of Oncology Trials

Leave a Comment / Press / Joel E

Enabling Successful Sites Ep. 3: Taking the Complexity Out of Oncology Trials Read More »

← Previous 1 2 3 Next →

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.

Who We Serve

Patients
Pharma
Hospitals & Oncology Practices

Services

Preclinical
Early Phase

About

Company
Leadership
Principal Investigators
Careers
Contact

Resources

Blog
Events
Newsroom
Patient Stories
Press
Publications
Webinars

START Locations

START - San Antonio
START - Midwest
START - Mountain Region
START - Carolinas
START - Madrid - CIOCC
START - Madrid - FJD
START - Barcelona
START - Rioja
START - Lisbon
START - Dublin

Patients & Family

Explore Clinical Trials
About Clinical Trials
Patient Stories

Referring Physicians

Find a Trial

Facebook Linkedin X-twitter

Privacy Policy
Cookie Policy
Site Map